Curaleaf Holdings, Inc.
CURLFOTC
Healthcare
Drug Manufacturers - Specialty & Generic
—
Curaleaf Holdings, Inc.
Revenue breakdown: Retail And Wholesale Revenue (66.6%), Wholesale Revenue (32.4%), Management Fee Income (1%).
—Mkt Cap
—Rev TTM
—NI TTM
Latest Earnings
40-F
FY FY2025Feb 26, 202640-F for FY2025 was filed on 2026-02-27. AI summary is not available yet.
Fundamentals
How The Business Makes Money
Revenue by Segment
Retail And Wholesale Revenue66.6%
Wholesale Revenue32.4%
Management Fee Income1%
Company Profile
CIK0001756770
ISINCA23126M1023
CUSIP23126M102
Phone781 451 0159
Address301 Edgewater Place, Wakefield, MA, 01880, US
SEC EDGAR